Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)

SHE:003017 Revenue

Zhe Jiang Dayang Biotech Group had revenue of 278.13M CNY in the quarter ending March 31, 2026, with 11.71% growth. This brings the company's revenue in the last twelve months to 1.07B, up 11.46% year-over-year. In the year 2025, Zhe Jiang Dayang Biotech Group had annual revenue of 1.05B with 14.89% growth.

• Revenue (ttm): 1.07B
• Revenue Growth: +11.46%
• P/S Ratio: 2.19
• Revenue / Employee: 1.39M
• Employees: 771
• Market Cap: 2.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.05B	135.48M	14.89%
Dec 31, 2024	909.96M	-9.50M	-1.03%
Dec 31, 2023	919.45M	-138.65M	-13.10%
Jan 1, 2023	1.06B	274.90M	35.10%
Dec 31, 2021	783.21M	104.87M	15.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error